These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31009764)
1. Nucleophosmin in leukemia: Consequences of anchor loss. Brodská B; Šašinková M; Kuželová K Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764 [TBL] [Abstract][Full Text] [Related]
2. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin. Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654 [TBL] [Abstract][Full Text] [Related]
3. Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM. Brodská B; Kráčmarová M; Holoubek A; Kuželová K PLoS One; 2017; 12(4):e0175175. PubMed ID: 28384310 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis. Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342 [TBL] [Abstract][Full Text] [Related]
5. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. den Besten W; Kuo ML; Williams RT; Sherr CJ Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118 [TBL] [Abstract][Full Text] [Related]